Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Launches WuXia ADCC PLUS™ for the Development and Manufacturing of Afucosylated Antibodies that Elicit Enhanced ADCC Effect 2024-01-25 08:30
FDA purchases digiM I2S software for the assessment of product quality attributes 2024-01-24 23:37
WestGene Spearheads Oncology Breakthroughs at the 3rd mRNA-Based Therapeutics Summit 2024-01-24 21:32
Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI 2024-01-24 21:00
Seegene Announces Collaboration with Microsoft to Realize 'a World Free from All Diseases' 2024-01-24 20:00
Sirnaomics Publishes Novel Mechanism of Action of RNAi Cancer Therapeutic STP707 for Solid Tumors 2024-01-24 17:49
Ascletis Announces Dosing of the First Patient in Phase III Clinical Trial of ASC40 (Denifanstat) for Treatment of Acne 2024-01-24 16:50
PRISM BioLab raises 1.5 billion yen in Series C fundraising to advance technologies and programs targeting protein-protein interactions 2024-01-24 16:00
Onward Therapeutics Announces Enrollment of Phase 1 Clinical Trial of a Novel Bispecific Antibody (OT-A201) Targeting Two Immune Checkpoints 2024-01-24 15:00
Harbour BioMed Announces IND Clearance for HBM9027 in the U.S. 2024-01-24 12:40
WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs) 2024-01-24 11:37
PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors 2024-01-24 10:01
Sciwind Biosciences Announces Positive Results from Phase 1 Clinical Trial of XW004, an Oral Formulation of Long-acting GLP-1 Analog Ecnoglutide 2024-01-24 10:00
INTREPID Alliance Releases Review of Antiviral Compounds in Clinical Development to Contribute to Collaborative Efforts in Pandemic Preparedness 2024-01-24 08:22
Akeso Presented Promising Results of Cadonilimab and Lenvatinib in Combination with TACE in uHCC at 2024 ASCO GI 2024-01-23 21:00
FDA Grants Breakthrough Device Designation to Amadix´s preventive screening blood test for Colorectal Cancer 2024-01-23 18:00
Gannex's Strategic Partner Sagimet Biosciences Announces Positive Topline Results from Phase 2b FASCINATE-2 Clinical Trial of Denifanstat in Biopsy-Confirmed F2/F3 NASH 2024-01-23 12:17
European Medicines Agency (EMA) Grants Orphan Drug Designation (ODD) to GC Biopharma's Treatment for Sanfilippo Syndrome (Type A) 2024-01-23 11:53
First Myeloma Patient Treated with CAR-T Successfully Discharged 2024-01-23 10:19
NK CellTech Announces FDA Clearance for Clinical Trial of NK010 2024-01-22 20:10
1 16 17 18 19 20 412